August 6, 2020, Santa Barbara, CA, USA
Santa Barbara Nutrients is honored to have three of our core team members, Thomas Weimbs, David Baron and Dwight Odland, in addition to two members of our Medical Advisory Board, Michal Mrug and Vicente Torres, featured as co-authors on this special report.
This report is the summary of an event where patients and many of the key opinion leaders, researchers, policy makers and nephrologists in the polycystic kidney disease field convened to discuss identification and implementation of a proposed core outcome set for future ADPKD clinical trials.
Thank you for all of your hard work on this important issue.
Click here for the story featured in the American Journal of Kidney Diseases:
Santa Barbara, California – April 27th, 2023 Santa Barbara Nutrients (SBN) is delighted to announce the appointment of Jessianna Saville to SBN’s advisory board, where she will bring her 17 years of renal nutrition experience as well as knowledge of building and...
Santa Barbara, California – May 22th, 2023 Santa Barbara Nutrients (SBN) is delighted to announce the appointment of Mr. Gregg Betz as Chief Executive Officer. With over 30 years of leadership across multiple industries and numerous countries, Gregg’s experience will...
May 9, 2022 - Thomas Weimbs, PhD & Jessianna Saville, RDN Autosomal dominant polycystic kidney disease (PKD) is a common genetic disorder with limited drug therapy options. PKD progresses relentlessly leading to dramatic and often painful kidney and liver...
Santa Barbara, CA, USA | April 27, 2023 Santa Barbara Nutrients (SBN) is delighted to announce the appointment of Mr. Glenn Frommer to SBN’s Board of Directors which expands the Board to five members. Glenn will leverage the experience from his nearly 40 years of...
0 Comments